Changes in alpha diversity in the weeks before anti-TNF-a treatment. حسب Katrine Carlsen (5477300)

"…The analysis found a significant association across all subjects for Shannon diversity with decreasing diversity in the lead up to the next treatment (lmer model, beta = -0.018, <i>p</i> = 0.036) and no association for observed diversity (<i>p</i>>0.1). …"

Voxel representation of a 3D binary image (left) and its corresponding graph of connected pore space voxels (right). حسب Mouad Klai (20818364)

Skills development and coping strategies as a consequence of the pandemic. <i><i>Results displayed in percentages.</i></i> حسب Katy Andrews (22311170)

Changes in vitamin A level from colostrum to mature milk (n = 10). حسب Saman Lashkari (21440154)

Graphs showing reproduction of selected South American annual case (a) and death (b) data using 1000 parameter sets drawn from post-burn-in distribution obtained from 4 Markov chai... حسب Keith Fraser (1868587)

Data Sheet 1_Placental trophoblast aging in advanced maternal age is related to increased oxidative damage and decreased YAP.docx حسب Song Guo (194234)

Data Sheet 2_Placental trophoblast aging in advanced maternal age is related to increased oxidative damage and decreased YAP.xls حسب Song Guo (194234)

Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease... حسب Donna E. Leet (22772478)

Linear Mixed-Effects Model analysis of bone mineral density changes in relation to urinary cadmium levels in a 3-Year Period. حسب Aroon La-up (14095691)

FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect. حسب Flavia Gomes Velasque Gama (21175112)

Everolimus decreased CD89 deposits in α1^KICD89^Tg mice. حسب Alexandra Cambier (22307216)

Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx حسب Juan Chen (61123)

"…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…"

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

597 SNPs for the candidate gene approach. حسب Dai Nogimura (21445649)

الموضوعات:

Definitions of traits for association analyses. حسب Dai Nogimura (21445649)

الموضوعات:

Summary of subscales or questions utilized to define traits. حسب Dai Nogimura (21445649)

الموضوعات:

Age and sex distribution of the participants. حسب Dai Nogimura (21445649)

الموضوعات:

Summary of sites of activity of genes encoded by SNPs observed to be associated in our study in the NO signaling pathway downstream of Cit. حسب Dai Nogimura (21445649)

الموضوعات: